Concepts (227)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Culicidae | 1 | 2017 | 239 | 0.60 | Why? |
| Insect Vectors | 1 | 2017 | 227 | 0.59 | Why? |
| Mosquito Control | 1 | 2017 | 237 | 0.59 | Why? |
| Respiratory Tract Infections | 6 | 2021 | 6817 | 0.45 | Why? |
| Measles virus | 3 | 2018 | 194 | 0.44 | Why? |
| Rubella | 2 | 2018 | 127 | 0.36 | Why? |
| Point-of-Care Testing | 2 | 2020 | 2782 | 0.36 | Why? |
| Influenza, Human | 11 | 2021 | 10779 | 0.35 | Why? |
| Truth Disclosure | 1 | 2010 | 196 | 0.33 | Why? |
| Statistics as Topic | 1 | 2010 | 370 | 0.33 | Why? |
| Respiratory Protective Devices | 2 | 2020 | 1637 | 0.32 | Why? |
| Virus Diseases | 3 | 2021 | 3779 | 0.31 | Why? |
| Serum | 1 | 2007 | 294 | 0.29 | Why? |
| Measles | 3 | 2018 | 608 | 0.29 | Why? |
| Zika Virus | 1 | 2017 | 1924 | 0.28 | Why? |
| Zika Virus Infection | 1 | 2017 | 1920 | 0.26 | Why? |
| Medical Staff, Hospital | 1 | 2014 | 1258 | 0.26 | Why? |
| Rubella virus | 2 | 2018 | 46 | 0.24 | Why? |
| Severe Acute Respiratory Syndrome | 5 | 2007 | 12361 | 0.23 | Why? |
| Respiratory Syncytial Virus Infections | 3 | 2021 | 1234 | 0.22 | Why? |
| Influenza A Virus, H1N1 Subtype | 4 | 2019 | 2984 | 0.20 | Why? |
| alpha-Tocopherol | 1 | 2019 | 37 | 0.20 | Why? |
| SARS Virus | 5 | 2007 | 13021 | 0.20 | Why? |
| Islam | 2 | 2017 | 545 | 0.19 | Why? |
| Australia | 11 | 2021 | 6306 | 0.19 | Why? |
| Pharynx | 1 | 2007 | 1544 | 0.19 | Why? |
| Polysorbates | 1 | 2019 | 125 | 0.19 | Why? |
| Rubella Syndrome, Congenital | 1 | 2018 | 17 | 0.18 | Why? |
| New South Wales | 4 | 2019 | 336 | 0.18 | Why? |
| Squalene | 1 | 2019 | 196 | 0.18 | Why? |
| Lymphocyte Subsets | 1 | 2005 | 987 | 0.18 | Why? |
| Research Report | 1 | 2021 | 376 | 0.16 | Why? |
| Reagent Kits, Diagnostic | 2 | 2015 | 2149 | 0.16 | Why? |
| Paramyxoviridae Infections | 1 | 2019 | 364 | 0.15 | Why? |
| Sentinel Surveillance | 3 | 2020 | 1093 | 0.15 | Why? |
| Microcephaly | 1 | 2017 | 181 | 0.15 | Why? |
| Genetic Variation | 3 | 2020 | 3919 | 0.15 | Why? |
| False Positive Reactions | 1 | 2020 | 1338 | 0.14 | Why? |
| Influenza Vaccines | 4 | 2019 | 2941 | 0.14 | Why? |
| Measles Vaccine | 1 | 2018 | 301 | 0.14 | Why? |
| Measles-Mumps-Rubella Vaccine | 1 | 2018 | 282 | 0.14 | Why? |
| Caliciviridae Infections | 1 | 2018 | 229 | 0.14 | Why? |
| Respiratory Syncytial Virus, Human | 2 | 2019 | 846 | 0.14 | Why? |
| Disease Notification | 1 | 2020 | 639 | 0.14 | Why? |
| HIV-1 | 2 | 2019 | 3365 | 0.13 | Why? |
| Norovirus | 1 | 2018 | 294 | 0.13 | Why? |
| Coinfection | 1 | 2014 | 6820 | 0.13 | Why? |
| Feces | 1 | 2007 | 4235 | 0.13 | Why? |
| Lymphopenia | 1 | 2005 | 2669 | 0.13 | Why? |
| Viruses | 2 | 2017 | 2238 | 0.12 | Why? |
| Quality Assurance, Health Care | 1 | 2017 | 596 | 0.12 | Why? |
| Fluorescent Antibody Technique | 1 | 2015 | 835 | 0.12 | Why? |
| Influenza A virus | 3 | 2019 | 2234 | 0.11 | Why? |
| RNA, Viral | 6 | 2020 | 32276 | 0.11 | Why? |
| Antibodies, Viral | 7 | 2021 | 51949 | 0.10 | Why? |
| Evolution, Molecular | 3 | 2019 | 3691 | 0.10 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2015 | 13720 | 0.10 | Why? |
| Cluster Analysis | 2 | 2018 | 3001 | 0.10 | Why? |
| Public Health Surveillance | 3 | 2019 | 3129 | 0.10 | Why? |
| Adjuvants, Immunologic | 1 | 2019 | 1709 | 0.10 | Why? |
| Antiviral Agents | 3 | 2018 | 41703 | 0.10 | Why? |
| Sensitivity and Specificity | 6 | 2020 | 22971 | 0.09 | Why? |
| Research | 1 | 2021 | 2115 | 0.09 | Why? |
| World Health Organization | 1 | 2021 | 4213 | 0.09 | Why? |
| Humans | 42 | 2021 | 930598 | 0.09 | Why? |
| Neuraminidase | 1 | 2010 | 289 | 0.09 | Why? |
| Infant | 7 | 2021 | 30274 | 0.09 | Why? |
| Zoonoses | 1 | 2021 | 3034 | 0.08 | Why? |
| Adult | 19 | 2021 | 244371 | 0.08 | Why? |
| Waste Water | 1 | 2018 | 2185 | 0.08 | Why? |
| Molecular Diagnostic Techniques | 2 | 2020 | 4239 | 0.08 | Why? |
| Oseltamivir | 1 | 2010 | 583 | 0.08 | Why? |
| HIV Seropositivity | 1 | 1988 | 320 | 0.08 | Why? |
| Leukocyte Common Antigens | 1 | 2005 | 101 | 0.07 | Why? |
| CD8 Antigens | 1 | 2005 | 72 | 0.07 | Why? |
| Nucleic Acid Amplification Techniques | 2 | 2017 | 3388 | 0.07 | Why? |
| Antigens, CD19 | 1 | 2005 | 98 | 0.07 | Why? |
| Disease Outbreaks | 4 | 2018 | 27595 | 0.07 | Why? |
| Public Health | 2 | 2017 | 16359 | 0.07 | Why? |
| Immunization Programs | 1 | 2018 | 2006 | 0.07 | Why? |
| Masks | 2 | 2020 | 8528 | 0.07 | Why? |
| CD4-CD8 Ratio | 1 | 2005 | 235 | 0.07 | Why? |
| Immunogenetics | 1 | 2004 | 124 | 0.07 | Why? |
| Pandemics | 10 | 2021 | 389249 | 0.07 | Why? |
| CD3 Complex | 1 | 2005 | 237 | 0.07 | Why? |
| Guillain-Barre Syndrome | 1 | 2017 | 1495 | 0.07 | Why? |
| Mutation, Missense | 1 | 2010 | 863 | 0.07 | Why? |
| CD4 Antigens | 1 | 2005 | 306 | 0.07 | Why? |
| Prevalence | 3 | 2020 | 25773 | 0.07 | Why? |
| Reproducibility of Results | 2 | 2017 | 11304 | 0.07 | Why? |
| HIV Infections | 2 | 2019 | 11620 | 0.06 | Why? |
| Drug Resistance, Viral | 1 | 2010 | 1083 | 0.06 | Why? |
| Seasons | 3 | 2021 | 4071 | 0.06 | Why? |
| Middle East | 2 | 2019 | 1418 | 0.06 | Why? |
| History, 20th Century | 1 | 2010 | 1282 | 0.06 | Why? |
| Female | 21 | 2021 | 380317 | 0.06 | Why? |
| Adolescent | 11 | 2021 | 86841 | 0.06 | Why? |
| Multivariate Analysis | 1 | 2014 | 5440 | 0.06 | Why? |
| DNA Primers | 2 | 2005 | 1170 | 0.06 | Why? |
| Genotype | 3 | 2019 | 4697 | 0.06 | Why? |
| Frozen Foods | 1 | 2021 | 22 | 0.06 | Why? |
| Male | 20 | 2021 | 367725 | 0.06 | Why? |
| Receptors, IgG | 1 | 2005 | 578 | 0.06 | Why? |
| Disease Eradication | 2 | 2018 | 581 | 0.06 | Why? |
| Travel | 2 | 2017 | 7220 | 0.05 | Why? |
| Genome, Viral | 2 | 2020 | 13157 | 0.05 | Why? |
| Middle Aged | 15 | 2021 | 270681 | 0.05 | Why? |
| Young Adult | 10 | 2021 | 93724 | 0.05 | Why? |
| Nasopharynx | 1 | 2020 | 10224 | 0.05 | Why? |
| Child, Preschool | 6 | 2021 | 36283 | 0.05 | Why? |
| Saudi Arabia | 3 | 2017 | 4423 | 0.05 | Why? |
| Food Contamination | 1 | 2021 | 142 | 0.05 | Why? |
| Animals | 5 | 2021 | 78931 | 0.05 | Why? |
| Australasia | 1 | 2019 | 89 | 0.05 | Why? |
| Nucleic Acid Hybridization | 1 | 1999 | 140 | 0.05 | Why? |
| Spleen | 1 | 2003 | 877 | 0.05 | Why? |
| Hemagglutination Inhibition Tests | 1 | 2019 | 191 | 0.05 | Why? |
| Phylogeny | 4 | 2019 | 13341 | 0.05 | Why? |
| Respirovirus | 1 | 2019 | 122 | 0.05 | Why? |
| Child | 8 | 2021 | 70012 | 0.05 | Why? |
| Seroepidemiologic Studies | 3 | 2021 | 10017 | 0.05 | Why? |
| Conflict of Interest | 1 | 2021 | 175 | 0.05 | Why? |
| Immunologic Tests | 1 | 2021 | 445 | 0.05 | Why? |
| Viral Load | 1 | 1999 | 15850 | 0.05 | Why? |
| Whole Genome Sequencing | 2 | 2020 | 3239 | 0.04 | Why? |
| Asia, Southeastern | 1 | 2019 | 390 | 0.04 | Why? |
| Evaluation Studies as Topic | 1 | 1999 | 391 | 0.04 | Why? |
| Mass Behavior | 1 | 2017 | 68 | 0.04 | Why? |
| Influenzavirus B | 1 | 2016 | 56 | 0.04 | Why? |
| Sequence Homology | 1 | 2018 | 448 | 0.04 | Why? |
| Health Education | 1 | 1988 | 1539 | 0.04 | Why? |
| Pregnancy | 4 | 2021 | 23879 | 0.04 | Why? |
| Lymph Nodes | 1 | 2003 | 1060 | 0.04 | Why? |
| Systems Analysis | 1 | 2020 | 366 | 0.04 | Why? |
| High-Throughput Nucleotide Sequencing | 2 | 2019 | 3633 | 0.04 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.04 | Why? |
| Immunoglobulin G | 4 | 2021 | 21571 | 0.04 | Why? |
| Hospitalization | 2 | 2017 | 54280 | 0.04 | Why? |
| Kinetics | 1 | 2004 | 3238 | 0.04 | Why? |
| Pregnancy Complications, Infectious | 2 | 2018 | 11559 | 0.04 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2015 | 11367 | 0.04 | Why? |
| Mutation Rate | 1 | 2018 | 382 | 0.04 | Why? |
| Lymphocyte Activation | 1 | 2005 | 2742 | 0.04 | Why? |
| Vietnam | 1 | 2020 | 1665 | 0.04 | Why? |
| Infant, Newborn | 3 | 2021 | 23105 | 0.04 | Why? |
| Occupational Exposure | 1 | 2014 | 4742 | 0.04 | Why? |
| Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2019 | 511 | 0.04 | Why? |
| Follow-Up Studies | 1 | 2014 | 17020 | 0.04 | Why? |
| Coronavirus Infections | 5 | 2020 | 253789 | 0.04 | Why? |
| Lung | 1 | 2003 | 31049 | 0.03 | Why? |
| North America | 1 | 2019 | 1400 | 0.03 | Why? |
| Antibodies, Neutralizing | 1 | 2021 | 25288 | 0.03 | Why? |
| Lymphocyte Count | 1 | 2005 | 4758 | 0.03 | Why? |
| Cooperative Behavior | 1 | 2021 | 1216 | 0.03 | Why? |
| Influenza B virus | 1 | 2019 | 815 | 0.03 | Why? |
| China | 3 | 2021 | 50654 | 0.03 | Why? |
| Immunity, Herd | 1 | 2021 | 1011 | 0.03 | Why? |
| Gastroenteritis | 1 | 2018 | 489 | 0.03 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.03 | Why? |
| Travel-Related Illness | 1 | 2020 | 1357 | 0.03 | Why? |
| Genotyping Techniques | 1 | 2015 | 360 | 0.03 | Why? |
| Aged | 8 | 2021 | 215776 | 0.03 | Why? |
| Molecular Epidemiology | 1 | 2018 | 1638 | 0.03 | Why? |
| HIV-2 | 1 | 1992 | 92 | 0.03 | Why? |
| Viral Proteins | 1 | 2010 | 7370 | 0.03 | Why? |
| Infection Control | 1 | 2020 | 23131 | 0.03 | Why? |
| History, 21st Century | 1 | 2017 | 1849 | 0.03 | Why? |
| Africa | 1 | 2019 | 2986 | 0.03 | Why? |
| Multiplex Polymerase Chain Reaction | 1 | 2018 | 1439 | 0.02 | Why? |
| Vaccination | 3 | 2019 | 19050 | 0.02 | Why? |
| Family Characteristics | 1 | 2020 | 2551 | 0.02 | Why? |
| Drug Combinations | 1 | 2019 | 3852 | 0.02 | Why? |
| Seroconversion | 1 | 2019 | 2515 | 0.02 | Why? |
| Nucleocapsid Proteins | 1 | 2021 | 3120 | 0.02 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2004 | 7868 | 0.02 | Why? |
| Prospective Studies | 1 | 2014 | 43301 | 0.02 | Why? |
| Aged, 80 and over | 4 | 2020 | 88759 | 0.02 | Why? |
| Vaccination Coverage | 1 | 2017 | 1249 | 0.02 | Why? |
| Politics | 1 | 2021 | 1824 | 0.02 | Why? |
| Epidemiological Monitoring | 1 | 2020 | 3493 | 0.02 | Why? |
| Blood Donors | 1 | 2021 | 2956 | 0.02 | Why? |
| Clinical Laboratory Techniques | 1 | 2014 | 23402 | 0.02 | Why? |
| Immunoglobulin M | 1 | 2004 | 9091 | 0.02 | Why? |
| Surveys and Questionnaires | 1 | 2014 | 43792 | 0.02 | Why? |
| Time Factors | 2 | 2021 | 31397 | 0.02 | Why? |
| Acquired Immunodeficiency Syndrome | 1 | 1992 | 533 | 0.02 | Why? |
| Global Health | 1 | 2010 | 13911 | 0.02 | Why? |
| Virology | 1 | 2010 | 489 | 0.02 | Why? |
| Gene Amplification | 1 | 2005 | 85 | 0.02 | Why? |
| Risk | 1 | 2018 | 5288 | 0.02 | Why? |
| Retrospective Studies | 3 | 2021 | 105322 | 0.02 | Why? |
| Odds Ratio | 1 | 2016 | 5861 | 0.02 | Why? |
| Vero Cells | 1 | 2021 | 14117 | 0.02 | Why? |
| Patient Discharge | 1 | 2021 | 5696 | 0.02 | Why? |
| Population Surveillance | 1 | 2020 | 4967 | 0.02 | Why? |
| Communicable Diseases, Emerging | 1 | 2018 | 2523 | 0.02 | Why? |
| Amino Acid Substitution | 1 | 2010 | 1706 | 0.02 | Why? |
| Tertiary Care Centers | 1 | 2021 | 8248 | 0.02 | Why? |
| Comorbidity | 2 | 2017 | 34796 | 0.02 | Why? |
| Europe | 1 | 2019 | 12702 | 0.01 | Why? |
| Sequence Analysis, DNA | 1 | 2010 | 2830 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2020 | 10649 | 0.01 | Why? |
| Sex Factors | 1 | 2018 | 11014 | 0.01 | Why? |
| Disease Models, Animal | 1 | 2018 | 10998 | 0.01 | Why? |
| Molecular Sequence Data | 1 | 2005 | 3198 | 0.01 | Why? |
| Severity of Illness Index | 2 | 2017 | 48226 | 0.01 | Why? |
| Incidence | 1 | 2021 | 25622 | 0.01 | Why? |
| Disease Management | 1 | 2016 | 6841 | 0.01 | Why? |
| Antigens, Viral | 1 | 2015 | 6298 | 0.01 | Why? |
| Risk Factors | 2 | 2017 | 71621 | 0.01 | Why? |
| Critical Care | 1 | 2021 | 14081 | 0.01 | Why? |
| Risk Assessment | 1 | 2021 | 25439 | 0.01 | Why? |
| Base Sequence | 1 | 2005 | 3581 | 0.01 | Why? |
| Age Factors | 1 | 2018 | 21039 | 0.01 | Why? |
| Mutation | 1 | 2017 | 12376 | 0.01 | Why? |
| Cytokines | 1 | 2018 | 15010 | 0.01 | Why? |
| DNA, Viral | 1 | 2005 | 2521 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2021 | 53120 | 0.01 | Why? |
| AIDS Serodiagnosis | 1 | 1992 | 64 | 0.01 | Why? |
| Africa, Western | 1 | 1992 | 363 | 0.01 | Why? |
| Communicable Disease Control | 1 | 2021 | 29620 | 0.01 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.01 | Why? |
| Treatment Outcome | 1 | 2018 | 51732 | 0.01 | Why? |
| Intensive Care Units | 1 | 2017 | 29594 | 0.01 | Why? |
| Blotting, Western | 1 | 1992 | 863 | 0.01 | Why? |
| Health Personnel | 1 | 2020 | 29646 | 0.01 | Why? |
| Polymerase Chain Reaction | 1 | 1992 | 6740 | 0.00 | Why? |
Dwyer's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(227)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(200)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_